Abstract:PURPOSE Isolated limb or liver perfusion with tumor necrosis factor (TNF) and melphalan results in regression of advanced cancers in the majority of treated patients. However, the contribution of TNF to the efficacy of isolation perfusion with melphalan has not been demonstrated conclusively in random assignment trials. Furthermore, TNF is an inflammatory cytokine and may be associated with significant systemic and regional toxicity. This study was conducted to characterize the toxicity and secondary cytokine production attributable to TNF by comparing these parameters in patients undergoing isolated hepatic perfusion (IHP) using melphalan with or without TNF. EXPERIMENTAL DESIGN Thirty-two patients with unresectable colorectal cancer confined to the liver underwent a 60-min hyperthermic IHP using 1.5 mg/kg melphalan alone (n = 17) or with 1.0 mg of TNF (n = 15) with inflow via the gastroduodenal artery and outflow via an isolated segment of inferior vena cava. Complete vascular isolation was confirmed using the I-131 radiolabeled albumin-monitoring technique. Post-IHP parameters of hepatic and systemic toxicity and cytokine levels [TNF, interleukin (IL)-6 and IL-8] in perfusate and serum were measured. RESULTS Levels of IL-6 and IL-8 in perfusate at the end of the 60-min IHP were significantly higher in TNF-treated patients (P < or = 0.001). Peak systemic IL-6 and IL-8 levels post-IHP were also significantly higher in TNF-treated compared with non-TNF-treated patients (P < 0.0001) by 28- and 268-fold, respectively. The peak levels of these cytokines were associated with significantly lower systolic blood pressure and higher heart rate and mean pulmonary artery blood pressure in TNF-treated patients during the first 48 h post-IHP (P < or = 0.03). Serum bilirubin levels were significantly higher (P = 0.017) and platelets lower (P = 0.03) in TNF-treated compared with non-TNF-treated patients. However, elevations in aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase were not significantly different between groups and returned toward baseline within 1 week after IHP. CONCLUSIONS Addition of TNF to melphalan during IHP results in significant differences in post-IHP production of IL-6 and IL-8 with associated changes in mean arterial blood pressure and greater regional toxicity, as reflected in higher levels of serum bilirubin. However, these measurable differences were transient and did not appear to be of major clinical consequence. Prior to its routine use, the benefit of TNF in isolation perfusion should be demonstrated in random assignment trials.

Restriction fragment length polymorphism analysis of major histocompatibility complex class II genes from inbred chicken lines.

Prevalence and Influencing Factors of Physical Restraints in Intensive Care Units: A Retrospective Cohort Study

Development and Implementation of a Novel Decision Support Tool on Physical Restraint Use in Critically Ill Adult Patients

“Patient Comfort Can Be Sacrificed for Patient Safety”—Perception and Practice Reported by Critical Care Nurses Toward Physical Restraints: A Qualitative Descriptive Study

The Effect of Non-Pharmacological Interventions on Physical Restraint Reduction in Intensive Care Units: a Protocol for an Umbrella Review of Systematic Reviews and Meta-Analysis.

The Use of Physical Restraints in Italian Intensive Care Units: Results From a Multicenter Observational Study

Tubular cryocoagulation: instrumentation for "no touch" melanoma enucleation and 360 degrees scleral buckling.

Prevalence of use of physical restraints in pediatric intensive care units and correlated variables: A Spanish multicenter study

Predicting Critical Care Nurses' Intention to Use Physical Restraints in Intubated Patients: A Structural Equation Model

Prevalence and variation of physical restraint use in acute care settings in the US

Age-related changes in the incorporation of [35S]sulfate into two proteoglycan populations from human cartilage.

The Current Status and Analysis of Physical Restraint Usage in Intensive Care Unit

The Use of Physical Restraints on Geriatric Patients: Culture and Attitudes among Healthcare Professionals at Intermediate Care Hospitals in Majorca. A Qualitative Study Protocol

Values and Preferences of Health Care Professionals, Policy-Makers, Patients and Family Members Regarding Recommendations of Adapted Physical Restraint Guidelines in Critical Care: A Survey Research

Role of tumor necrosis factor on toxicity and cytokine production after isolated hepatic perfusion.

Physical restraints in nursing homes: A qualitative study with multiple stakeholders

Physical restraint intervention in the intensive care unit: An observational pilot study

Between Restrictive and Supportive Devices in the Context of Physical Restraints: Findings from a Large Mixed-Method Study Design

Factors Influencing Nursing Practice for Physical Restraints among Nurses in the Intensive Care Unit

Adverse events related to physical restraint use in intensive care units: A review of the literature

Family perspectives on physical restraint practices and minimization in an adult intensive care unit: A qualitative descriptive study